Skip to content

Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling

Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04342091
Enrollment
6
Registered
2020-04-10
Start date
2021-04-09
Completion date
2022-04-08
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Centrifugal Cicatricial Alopecia, Fibrosing Alopecia, Frontal Fibrosing Alopecia

Brief summary

To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.

Detailed description

The investigators propose an open label trial of tattoo machine microneedling in ten patients with fibrosing alopecia (five patients with CCCA and five with FFA). Ten healthy female patients older than 18 years will undergo 6 microneedling sessions. Over the course of six months, subjects will undergo up to six treatment sessions (one session every 30 day). Photographs will be taken at each session. Patients will be evaluated at 8 visits over 8 months with the first visit for screening purposes. Each visit will last about an hour. Approximately 30 minutes will be spent on consenting and time for patient to ask questions during the first visit. The remaining 30 minutes will be allotted for the investigator to determine if the patient meets criteria for trial enrollment. During the remaining visits, 20 minutes will be allotted for photography, 15-20 minutes for the procedure and 10-15 minutes for post-procedure patient assessment. Remaining 10 minutes on visits 2 and 8 will be used for biopsy.

Interventions

DEVICESOL Nova Device

A SOL Nova Device (brand) is tattoo machine will be used to stimulate hair regrowth.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy Female * Diagnosing Fibrosing alopecia

Exclusion criteria

* Any female with hair loss for other reasons * Males * Patients with cardiac conditions or renal insufficiency * Pregnant patients * Patients containing the following who would make poor candidates for microneedling, such as skin conditions, diabetes, history of keloid formation * Anything additional existing comorbidities that in the opinion of the investigator may cause unnecessary risk for the patient to participate

Design outcomes

Primary

MeasureTime frameDescription
Total Area Hair Count (Frontal)6 monthsTotal number of hairs over an area of 1cm\^2
Total Area Hair Count (Vertex)6 monthsTotal number of hairs over an area of 1 cm\^2

Secondary

MeasureTime frameDescription
Number of Hair Follicles (Frontal)6 monthsNumber of hair follicles counted per 1cm\^2
Number of Hair Follicles (Vertex)6 monthsNumber of hair follicles per 1 cm\^2
Vellus Hairs (Frontal)6 monthsNumber of vellus hairs per cm\^2
Hair Shaft Diameters (Frontal)6 monthsHair shaft diameter measured per trichoscopy
Terminal Hairs (Frontal)6 monthsNumber of terminal hairs over an area of 1 cm\^2
Terminal Hairs (Vertex)6 monthsNumber of terminal hairs per area of 1 cm\^2
Vellus Hairs (Vertex)6 monthsNumber of vellus hairs per cm\^2
Hair Shaft Diameters (Vertex)6 monthsHair shaft diameter measured per trichoscopy

Countries

United States

Participant flow

Participants by arm

ArmCount
Microneedling
Participants with fibrosing alopecia will receive microneedling with a tattoo machine. SOL Nova Device: A SOL Nova Device (brand) is tattoo machine will be used to stimulate hair regrowth.
6
Total6

Baseline characteristics

CharacteristicMicroneedling
Age, Continuous58.8 years
STANDARD_DEVIATION 10.5
Hair shaft diameter (frontal)62.3 micrometer
STANDARD_DEVIATION 16.5
Hair shaft diameter (vertex)72.2 micrometer
STANDARD_DEVIATION 7.1
Number of hair follicles (frontal)46.0 follicle count per cm^2
STANDARD_DEVIATION 55.8
Number of hair follicles (vertex)31.5 follicle count per cm^2
STANDARD_DEVIATION 2.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
0 Participants
Terminal hairs (frontal)49.3 Count per cm^2
STANDARD_DEVIATION 66.8
Terminal hairs (vertex)32.5 Count per cm^2
STANDARD_DEVIATION 6.4
Total area hair count (frontal)50.0 Count per cm^2
STANDARD_DEVIATION 66.3
Total hair count (vertex)32.5 Count per cm^2
STANDARD_DEVIATION 6.4
Vellus hairs (frontal)0.8 Count per cm^2
STANDARD_DEVIATION 1.5
Vellus hairs (vertex)0 Count per cm^2
STANDARD_DEVIATION 0

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 6
other
Total, other adverse events
2 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Total Area Hair Count (Frontal)

Total number of hairs over an area of 1cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTotal Area Hair Count (Frontal)86.8 Count per cm^2Standard Deviation 73
Primary

Total Area Hair Count (Vertex)

Total number of hairs over an area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTotal Area Hair Count (Vertex)117.5 Count per cm^2Standard Deviation 115.3
Secondary

Hair Shaft Diameters (Frontal)

Hair shaft diameter measured per trichoscopy

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingHair Shaft Diameters (Frontal)61.1 micrometerStandard Deviation 19.6
Secondary

Hair Shaft Diameters (Vertex)

Hair shaft diameter measured per trichoscopy

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingHair Shaft Diameters (Vertex)63.5 micrometerStandard Deviation 5.2
Secondary

Number of Hair Follicles (Frontal)

Number of hair follicles counted per 1cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingNumber of Hair Follicles (Frontal)70.3 Count per cm^2Standard Deviation 59.6
Secondary

Number of Hair Follicles (Vertex)

Number of hair follicles per 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingNumber of Hair Follicles (Vertex)74.0 Count per cm^2Standard Deviation 53.7
Secondary

Terminal Hairs (Frontal)

Number of terminal hairs over an area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTerminal Hairs (Frontal)85.3 Count per cm^2Standard Deviation 74.6
Secondary

Terminal Hairs (Vertex)

Number of terminal hairs per area of 1 cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingTerminal Hairs (Vertex)117.5 Count per cm^2Standard Deviation 115.3
Secondary

Vellus Hairs (Frontal)

Number of vellus hairs per cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingVellus Hairs (Frontal)1.5 Count per cm^2Standard Deviation 3
Secondary

Vellus Hairs (Vertex)

Number of vellus hairs per cm\^2

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
MicroneedlingVellus Hairs (Vertex)0 Count per cm^2Standard Deviation 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026